|
Index of reports
> Life Threatening Events (4)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Novolog MIX 70 / 30 life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Novolog MIX 70 / 30 side effects in 56 year old male
Reported by a pharmacist from United States on 2012-05-22
Patient: 56 year old male
Reactions: Blood Glucose Decreased, Confusional State, Product Quality Issue, Hyperhidrosis, Hunger, Loss of Consciousness
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Novolog MIX 70 / 30
Possible Novolog MIX 70 / 30 side effects in 73 year old female
Reported by a consumer/non-health professional from China on 2012-03-01
Patient: 73 year old female
Reactions: Shock
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Novolog MIX 70 / 30
Possible Novolog MIX 70 / 30 side effects in
Reported by a consumer/non-health professional from China on 2011-12-07
Patient:
Reactions: Product Counterfeit, Shock
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Novolog MIX 70 / 30
Possible Novolog MIX 70 / 30 side effects in 85 year old female
Reported by a health professional (non-physician/pharmacist) from Germany on 2011-10-27
Patient: 85 year old female, weighing 70.0 kg (154.0 pounds)
Reactions: Syncope, Hypoglycaemia, Drug Interaction
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Novolog MIX 70 / 30
Dosage: unk
Indication: Type 2 Diabetes Mellitus
Start date: 2000-01-01
End date: 2008-12-14
Actrapid
Dosage: unk
Indication: Type 2 Diabetes Mellitus
Start date: 2009-01-07
Carvedilol
Dosage: 6.25 mg, bid
Administration route: Oral
Indication: Cardiac Failure
Start date: 2008-11-07
End date: 2008-12-14
Lantus
Dosage: 6 iu, qd
Indication: Type 2 Diabetes Mellitus
Start date: 2000-01-01
Repaglinide
Dosage: 2 mg, tid
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2000-01-01
End date: 2008-12-14
Enalapril Maleate
Dosage: 2.5 mg, bid
Administration route: Oral
Indication: Cardiac Failure
Start date: 2008-11-07
End date: 2008-12-14
Other drugs received by patient: Allopurinol; Omeprazole; Torsemide; Levothyroxine Sodium; Digitoxin TAB; Spironolactone
|
